Literature DB >> 26011179

The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington's disease.

Joanne Kim1,2, Henry J Waldvogel1,2, Richard L M Faull1,2, Maurice A Curtis1,2, Louise F B Nicholson1,2.   

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by an expansion of the CAG repeat in the huntingtin gene. One of the brain changes that occurs in HD is the expression of the receptor for advanced glycation end products (RAGE), a receptor protein capable of activating multiple signalling pathways by interacting with a range of ligands leading to either beneficial or harmful effects to the cell. Here, we demonstrate in human HD brains a high degree of co-localization of RAGE with its putative ligands S100B and N-carboxymethyllysine (CML) in the caudate nucleus (CN) and the subependymal layer (SEL). The level of co-staining for both RAGE-S100B and RAGE-CML was the highest in the astrocytes but was low in neurons and microglia. The immunostaining for RAGE, S100B and CML extended in a medio-lateral (SEL-CN) direction with increasing grade, such that any change in the expression and co-localization pattern between grades was less prominent in the lateral CN. Additionally, signalling molecules that are downstream of RAGE activation showed changes in their activation status in HD brains. A larger number of RAGE-positive astrocytic cells had NF-kB translocated to the nucleus and the level of phospho-ERK1/2 was also increased in HD brains. Interestingly, the level of mDia-1, that interacts directly with the cytoplasmic domain of RAGE, decreased in HD. Overall, the results suggest a correlation between the functions of RAGE and the HD pathology, but the influence of RAGE on astrocytes and the impact of this on HD progression requires further study. RAGE (receptor for advanced glycation end products) binds multiple types of ligand to produce either neurotrophic or neurotoxic effects. Immunohistochemical staining of HD human brains showed that both RAGE and its ligands were expressed primarily in astrocytes. The pattern of staining corresponded to the grade and region-wise pattern of neurodegeneration suggesting a possible role for RAGE in HD pathology.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  Huntington's disease; N-carboxymethyllysine; S100B; astrocytes; receptor for advanced glycation end products

Mesh:

Substances:

Year:  2015        PMID: 26011179     DOI: 10.1111/jnc.13178

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

Review 1.  Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  J Mol Med (Berl)       Date:  2020-02-08       Impact factor: 4.599

Review 2.  Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease.

Authors:  Seigmund Wai Tsuen Lai; Edwin De Jesus Lopez Gonzalez; Tala Zoukari; Priscilla Ki; Sarah C Shuck
Journal:  Chem Res Toxicol       Date:  2022-10-05       Impact factor: 3.973

Review 3.  Role of RAGE in the Pathogenesis of Neurological Disorders.

Authors:  Judyta Juranek; Konark Mukherjee; Bernard Kordas; Michał Załęcki; Agnieszka Korytko; Kamila Zglejc-Waszak; Jarosław Szuszkiewicz; Marta Banach
Journal:  Neurosci Bull       Date:  2022-06-21       Impact factor: 5.271

Review 4.  Sterile Neuroinflammation and Strategies for Therapeutic Intervention.

Authors:  Manoj Banjara; Chaitali Ghosh
Journal:  Int J Inflam       Date:  2017-01-03

5.  The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93A Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes.

Authors:  Alessia Serrano; Claudia Donno; Stefano Giannetti; Mina Perić; Pavle Andjus; Nadia D'Ambrosi; Fabrizio Michetti
Journal:  Mediators Inflamm       Date:  2017-06-20       Impact factor: 4.711

Review 6.  Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.

Authors:  Inês Caldeira Brás; Annekatrin König; Tiago Fleming Outeiro
Journal:  J Huntingtons Dis       Date:  2019

7.  Receptor for Advanced Glycation End Products (RAGE) Mediates Cognitive Impairment Triggered by Pneumococcal Meningitis.

Authors:  Vijayasree V Giridharan; Jaqueline S Generoso; Allan Collodel; Diogo Dominguini; Cristiano Julio Faller; Flavio Tardin; Gursimrat S Bhatti; Fabricia Petronilho; Felipe Dal-Pizzol; Tatiana Barichello
Journal:  Neurotherapeutics       Date:  2021-01       Impact factor: 7.620

8.  High glucose-induced complement component 3 up-regulation via RAGE-p38MAPK-NF-κB signalling in astrocytes: In vivo and in vitro studies.

Authors:  Yuxing Zhao; Cheng Luo; Jinliang Chen; Yue Sun; Die Pu; Ankang Lv; Shiyu Zhu; Jing Wu; Meili Wang; Jing Zhou; Zhiyin Liao; Kexiang Zhao; Qian Xiao
Journal:  J Cell Mol Med       Date:  2018-09-24       Impact factor: 5.310

9.  Nuclear inclusions of pathogenic ataxin-1 induce oxidative stress and perturb the protein synthesis machinery.

Authors:  Stamatia Laidou; Gregorio Alanis-Lobato; Jan Pribyl; Tamás Raskó; Boris Tichy; Kamil Mikulasek; Maria Tsagiopoulou; Jan Oppelt; Georgia Kastrinaki; Maria Lefaki; Manvendra Singh; Annika Zink; Niki Chondrogianni; Fotis Psomopoulos; Alessandro Prigione; Zoltán Ivics; Sarka Pospisilova; Petr Skladal; Zsuzsanna Izsvák; Miguel A Andrade-Navarro; Spyros Petrakis
Journal:  Redox Biol       Date:  2020-02-11       Impact factor: 11.799

Review 10.  Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System.

Authors:  Patrizia Hrelia; Giulia Sita; Marina Ziche; Emma Ristori; Angela Marino; Marika Cordaro; Raffaella Molteni; Vittoria Spero; Marco Malaguti; Fabiana Morroni; Silvana Hrelia
Journal:  Oxid Med Cell Longev       Date:  2020-08-01       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.